Peanut allergy: Beyond the oral immunotherapy plateau
Authors:
Open Access
- 13 August 2021
- journal article
- review article
- Published by Wiley in Clinical and Translational Allergy
- Vol. 11 (6) , e12046
Abstract
Background: There are a lack of disease‐modifying treatments for peanut allergy, which is lifelong in most instances. Oral immunotherapy has remained at the forefront of prospective treatments, though its efficacy is consistently undermined by the risk of adverse reactions and meager sustained effects.Aim: This review discusses the current state of oral immunotherapy, its strengths and limitations, and the future of therapeutics for the treatment of peanut allergy.Conclusion: The persistence of peanut allergy is currently attributed to reservoirs of peanut‐specific memory B cells and Th2 cells, though the cellular and molecular interplay that facilitates the replenishment of peanut‐specific IgE remains elusive. Uncovering these events will prove critical for identification of novel targets as we forge ahead to a new age of peanut allergy treatment with biotherapeutics.Keywords
This publication has 29 references indexed in Scilit:
- Early oral immunotherapy in peanut-allergic preschool children is safe and highly effectiveJournal of Allergy and Clinical Immunology, 2017
- Changes over Time in IgE Sensitization to Allergens of the Fish Parasite Anisakis spp.PLOS Neglected Tropical Diseases, 2016
- Human B-cell isotype switching origins of IgEJournal of Allergy and Clinical Immunology, 2016
- Oral immunotherapy for the treatment of food allergyHuman Vaccines & Immunotherapeutics, 2014
- Fish and shellfish allergy in children: Review of a persistent food allergyPediatric Allergy and Immunology, 2012
- Accidental ingestions in children with peanut allergyJournal of Allergy and Clinical Immunology, 2006
- Saisonale Schwankungen des Serum-IgE-Spiegels und deren mögliche Bedeutung für die Berechnung der therapeutischen Dosis von Omalizumab (rhuMab-E25, anti-IgE)Pneumologie, 2004
- Food allergy in children: results of a standardized protocol for oral desensitization.1998
- Regulation of murine in vivo lgG and lgE responses by a monoclonal anti-IL-4 receptor antibodyInternational Immunology, 1991
- A CASE OF EGG POISONING.The Lancet, 1908